Experts find improved glucose metabolism using subcutaneous insulin

06/9/2011 | HealthDay News

Continuous subcutaneous insulin infusion improved the fasting gluconeogenesis and glycogen cycling in patients with poorly controlled type 1 diabetes, a study in the journal Diabetes found. CSII-treated patients had 70% lower net hepatic glycogen synthesis and 42% higher endogenous glucose production than a control group.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA